" class="no-js "lang="en-US"> Yutaka Yamaguchi - Medtech Alert
Monday, September 25, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Yutaka Yamaguchi

Yutaka Yamaguchi

About Yutaka Yamaguchi

Related Story

News

 Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility | PTF

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

November 22 2022

FUJIFILM Corporation has announced a $188 million investment to establish a cell culture media manufacturing […]

Artificial Intelligence

 FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF | Pharmtech Focus

FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF

June 23 2022

FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell […]

Industry News

 Fujifilm to Acquire Shenandoah Biotechnology

Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins

March 23 2022

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, […]

Industry News

 FUJIFILM Irvine Scientific Opens European Manufacturing Facility | Pharmtech Focus

FUJIFILM Irvine Scientific Opens European Manufacturing Facility

December 8 2021

FUJIFILM Irvine Scientific, Inc., today announced that its new manufacturing facility in Tilburg, the Netherlands is […]

News

 FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility | Pharmtech Focus

FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility

September 29 2021

FUJIFILM Irvine Scientific, Inc., today announced that it completed construction and started the commissioning phase of its […]